Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 64,788 | 44,660 | 27,325 | 20,441 | 28,219 |
| Receivables | 9,741 | 7,768 | 5,234 | 8,482 | 5,226 |
| Inventories | 20,424 | 9,192 | 14,525 | 14,677 | 13,601 |
| Other current assets | 541 | 0 | 0 | 0 | 0 |
| TOTAL | $96,806 | $64,102 | $49,534 | $46,567 | $48,905 |
| Non-Current Assets | |||||
| PPE Net | 1,323 | 1,719 | 2,137 | 2,799 | 3,003 |
| Intangibles | 5,660 | 359 | 510 | 671 | 857 |
| Other Non-Current Assets | 2,617 | 2,098 | 2,783 | 4,020 | 5,075 |
| TOTAL | $9,600 | $4,176 | $5,430 | $7,490 | $8,935 |
| Total Assets | $106,406 | $68,278 | $54,964 | $54,057 | $57,840 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,796 | 8,526 | 10,232 | 9,679 | 10,423 |
| Accrued Expenses | 7,722 | 7,817 | 9,493 | 7,337 | 6,481 |
| Other current liabilities | 399 | 611 | 195 | 157 | 161 |
| TOTAL | $19,919 | $17,948 | $20,622 | $17,869 | $17,613 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,815 | 1,657 | 2,563 | 3,539 | 4,154 |
| TOTAL | $9,954 | $4,236 | $5,886 | $7,516 | $8,500 |
| Total Liabilities | $29,873 | $22,184 | $26,508 | $25,385 | $26,113 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 80,080 | 77,750 | 75,309 | 74,838 | 68,309 |
| Common Shares | 79 | 77 | 75 | 74 | 68 |
| Retained earnings | -164,528 | -181,910 | -190,460 | -185,493 | -168,953 |
| Other shareholders' equity | -9 | -4 | -4 | -3 | -2 |
| TOTAL | $76,533 | $46,094 | $28,456 | $28,672 | $31,727 |
| Total Liabilities And Equity | $106,406 | $68,278 | $54,964 | $54,057 | $57,840 |